Economic evaluation protocol of a short, all-oral bedaquiline-containing regimen for the treatment of rifampicin-resistant tuberculosis from the STREAM trial by Rosu, Laura, Madan, Jason, Worrall, Eve, Tomeny, Ewan, Squire, Bertel, Girma, Mamo, Patel, Vanita, Mukesh, Makwana, Muniyandi, Malaisamy, Kumar, Shravan, Subramani, Sangeetha, Ahmad, Saleem, Nidoi, Jasper, Pirlog, Irina, Macarie, Mariana, Rusen, ID, Bronson, Gay, Gurumurthy, Meera, Sanders, Karen, Meredith, Sarah, Nunn, Andrew, Ben Spittle, Wendy Dodds, Henry-Cockles, Robyn, Bennett, Rachel, Giallongo, Elisa, Maas, Danni, Goodall, Ruth, Ahmed, Saiam, Cook, Claire, Bellenger, Katharine, Narendran, Gopalan, Kirenga, Bruce, Tudor, Elena, Solanki, Rajesh, Meressa, Daniel, Bayissa, Adamu, Bhatnagar, Anuj

Get full text

PA-675 Navigating the COVID-19 pandemic for participant recruitment and follow-up: experiences from the PediCAP clinical trial consortium by Kiggwe, Andrew, Nalwanga, Damalie, Tagoola, Abner, Madhi, Shabir, Moore, David, Archary, Moherndran Archary, Mulenga, Veronica, Mujuru, Hilda Angela, Sacarlal, Jahit, Buck, Chris, Sidat, Muhammad, Nguyen, Hanh, Haque, Farjana, Dennis, Emily, Clements, Michelle, Murphy, Brendan, Spittle, Ben, Viero, Francesca, Bielick, Julia, Musiime, Victor, Sharland, Mike

Request full text

DNA-Dependent Protein Kinase (DNA-PK) Inhibitors. Synthesis and Biological Activity of Quinolin-4-one and Pyridopyrimidin-4-one Surrogates for the Chromen-4-one Chemotype by Cano, Céline, Barbeau, Olivier R, Bailey, Christine, Cockcroft, Xiao-Ling, Curtin, Nicola J, Duggan, Heather, Frigerio, Mark, Golding, Bernard T, Hardcastle, Ian R, Hummersone, Marc G, Knights, Charlotte, Menear, Keith A, Newell, David R, Richardson, Caroline J, Smith, Graeme C. M, Spittle, Ben, Griffin, Roger J

Get full text